Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
SBC Medical Group Holdings Incorporated(SBC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for SBC
10/23/2026: SBC (2-star) has a low Upturn Star Rating. Not recommended to BUY.
SBC Medical Group Holdings is a Japan-focused provider of management services and medical equipment leasing for aesthetic clinics. The company benefits from a scalable business model that supports standardized clinical operations and has a recognized brand in its local market. Its primary growth opportunity lies in expanding its partner clinic network and potentially scaling into broader Asian markets. However, investors face risks from geographic concentration, potential regulatory changes, and economic sensitivity affecting discretionary spending. The stock may suit growth-oriented investors looking for exposure to the aesthetic medical services industry, provided they monitor the company's success in scaling its model effectively.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company operates in the high-demand aesthetic medical sector with a scalable management model. |
| Momentum investor | Mixed fit | Fit is conditional on positive price trends following the company's recent listing. |
| Value investor | Weak fit | The valuation reflects growth expectations typical of early-stage listed service companies. |
| Dividend investor | Weak fit | The company currently prioritizes reinvestment for growth over dividend payments. |
| Low-risk investor | Weak fit | Market and regulatory risks associated with the aesthetic industry create high volatility potential. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Recent listing status and exposure to consumer discretionary spending contribute to price swings. |
| Valuation risk | Medium / high | Growth-oriented valuations can be sensitive to quarterly performance misses. |
| Competition risk | Medium | The aesthetic services market in Japan is competitive and sensitive to new entrants. |
| Business quality | Medium | The model depends on the execution quality of the clinics it supports. |
| Dividend income | Low / none | No current focus on returning capital via dividends. |
| Execution risk | Medium | Scaling the management model successfully requires consistent operational oversight. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 35.28% | Avg. Invested days 59 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 10/23/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 543.03M USD | Price to earnings Ratio 12 | 1Y Target Price 8.75 |
Price to earnings Ratio 12 | 1Y Target Price 8.75 | ||
Volume (30-day avg) 214.5K shares | Beta 0.55 | 52 Weeks Range 2.78 - 5.79 | Updated Date 10/24/2026 |
52 Weeks Range 2.78 - 5.79 | Updated Date 10/24/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.44 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Management Support Services | Marketing, staffing, and administrative support fees. | The core revenue comes from managing the back-office needs of aesthetic clinics. |
| Medical Equipment Leasing | Leasing fees for high-end aesthetic medical devices. | Revenue is generated by providing the tools clinics need to perform procedures. |
| Geography: Japan | Primary operations and clinic network. | The company is heavily concentrated in the Japanese market. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE 12 | Forward PE 7 | Enterprise Value 296.69M | Price to Sales(TTM) 3.1 |
Enterprise Value 296.69M | Price to Sales(TTM) 3.1 | ||
Enterprise Value to Revenue 1.58 | Enterprise Value to EBITDA 4.4 | Shares Outstanding 102.85M | Shares Floating 18.10M |
Shares Outstanding 102.85M | Shares Floating 18.10M | ||
Percent Insiders 81.53 | Percent Institutions 4.44 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.